A Study of Uveitis in Children <18 Years of Age
Key facts
- Who runs it
- Jaeb Center for Health Research
- Where
- Akron, Boston, Cincinnati, and Columbus, United StatesSee the 4 sites
- Trial code
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 14 Apr 2026
- Expected to end
- 1 Apr 2028
- Type of study
- Observational, 2 groups
- Record updated
- 2 November 2026
Who can take part
- Age
- Up to 17 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age:; Incident cases (onset ≤ 6 months) <17 years; Established cases (onset > 6 months) <18 years
- Diagnosis of any type of uveitis (infectious or noninfectious) in any location except traumatic and post-operative uveitis
- Active or inactive uveitis with any treatment status (current / prior / none [but under surveillance])
Who cannot take part
- Ocular disease related to Retinoblastoma, Coat's disease, retinitis pigmentosa, inherited retinal degeneration, Juvenile xanthogranuloma (JXG), or leukemia/malignancy within the eye
- Bilateral uveitis with differing etiologies
- Traumatic uveitis
- Post-operative uveitis
- Immediate family member (spouse, biological or legal guardian, child, sibling, parent) who is an investigative site personnel directly affiliated with this study or who is an employee of JAEB Center for Health Research
Where in United States
- Akron Children's HospitalAkron, United StatesContact: Cassandra S Solis, O.DTaking people
- Department of Ophthalmology, Boston University School of MedicineBoston, United StatesContact: Kara C LaMattina, MDTaking people
- Cincinnati Children's Hospital Medical CenterCincinnati, United StatesContact: Virginia Miraldi Utz, MDTaking people
- Pediatric Ophthalmology Associates, Inc.Columbus, United StatesContact: Catherine O Jordan, MDTaking people
About the trial
What the trial wants to find out
The goal of this observational study is to collect data regarding clinical features and current/past treatments in children under 18 with uveitis. The main questions it aims to answer are:
Read full original descriptionShow less
* What are the frequency of uveitis subtypes in children? * What are clinical and demographic characteristics overall and within each type of uveitis?
Participants will complete one enrollment visit with their doctor. Participants with uveitis onset <6 months from enrollment date will also partake in a 12 month chart review.
The 2 groups in the trial
- Children diagnosed with uveitis - established cases
Children diagnosed with uveitis (onset \> 6 months), either active or inactive with or without current treatment at time of enrollment.
- Children diagnosed with uveitis - incident cases
Children diagnosed with uveitis (onset ≤ 6 months), either active or inactive with or without current treatment at time of enrollment.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 2 November 2026